Document Detail


Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
MedLine Citation:
PMID:  22315267     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Objective testing for DVT is crucial because clinical assessment alone is unreliable and the consequences of misdiagnosis are serious. This guideline focuses on the identification of optimal strategies for the diagnosis of DVT in ambulatory adults.
METHODS: The methods of this guideline follow those described in Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
RESULTS: We suggest that clinical assessment of pretest probability of DVT, rather than performing the same tests in all patients, should guide the diagnostic process for a first lower extremity DVT (Grade 2B). In patients with a low pretest probability of first lower extremity DVT, we recommend initial testing with D-dimer or ultrasound (US) of the proximal veins over no diagnostic testing (Grade 1B), venography (Grade 1B), or whole-leg US (Grade 2B). In patients with moderate pretest probability, we recommend initial testing with a highly sensitive D-dimer, proximal compression US, or whole-leg US rather than no testing (Grade 1B) or venography (Grade 1B). In patients with a high pretest probability, we recommend proximal compression or whole-leg US over no testing (Grade 1B) or venography (Grade 1B).
CONCLUSIONS: Favored strategies for diagnosis of first DVT combine use of pretest probability assessment, D-dimer, and US. There is lower-quality evidence available to guide diagnosis of recurrent DVT, upper extremity DVT, and DVT during pregnancy.
Authors:
Shannon M Bates; Roman Jaeschke; Scott M Stevens; Steven Goodacre; Philip S Wells; Matthew D Stevenson; Clive Kearon; Holger J Schunemann; Mark Crowther; Stephen G Pauker; Regina Makdissi; Gordon H Guyatt;
Related Documents :
22694977 - Use of a rapid visual screening tool for the assessment of concussion in amateur rugby ...
4218967 - A simple double immunodiffusion test for typing influenza viruses.
22512667 - Assaying embryotoxicity in the test tube: current limitations of the embryonic stem cel...
21571737 - A five-factor measure of schizotypal personality traits.
19362877 - Assessment of computer generated vision charts.
18935807 - A biomechanical assessment of the coupling of torsion and tension in the human scapholu...
Publication Detail:
Type:  Journal Article; Practice Guideline    
Journal Detail:
Title:  Chest     Volume:  141     ISSN:  1931-3543     ISO Abbreviation:  Chest     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-02-08     Completed Date:  2012-04-13     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e351S-418S     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada. batesm@mcmaster.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Ambulatory Care
Evidence-Based Medicine*
Female
Fibrin Fibrinogen Degradation Products / analysis
Fibrinolytic Agents / adverse effects,  therapeutic use*
Hemorrhage / blood,  chemically induced,  prevention & control
Humans
Magnetic Resonance Angiography / methods
Male
Phlebography / methods
Predictive Value of Tests
Probability
Pulmonary Embolism / diagnosis,  drug therapy,  prevention & control
Risk Factors
Societies, Medical*
Thrombosis / diagnosis*,  drug therapy*,  prevention & control
Tomography, X-Ray Computed / methods
Ultrasonography / methods
United States
Venous Thrombosis / diagnosis*,  drug therapy*,  prevention & control
Chemical
Reg. No./Substance:
0/Fibrin Fibrinogen Degradation Products; 0/Fibrinolytic Agents; 0/fibrin fragment D
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombo...
Next Document:  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:...